Starting an IVF cycle involves learning an entirely new vocabulary, and ovarian hyperstimulation syndrome, often shortened to OHSS, is one term worth understanding before treatment begins. OHSS is a potential response to the fertility medications used to stimulate egg production, and while most cases are mild, being able to recognize the signs can help you know when to contact your clinic.
For women over 35 undergoing ovarian stimulation, understanding OHSS alongside the rest of the ovulation induction process can make the experience feel less unpredictable, even though individual responses to medication vary considerably.
What Research Shows About OHSS
According to research summarized by the Mayo Clinic, mild OHSS occurs in an estimated 20 to 33 percent of IVF cycles, while moderate to severe forms are considerably less common, affecting roughly 1 to 5 percent of cycles. OHSS develops when the ovaries respond strongly to stimulation medications, becoming enlarged and, in some cases, leaking fluid into the abdominal cavity.
Interestingly, OHSS risk is not necessarily higher simply because of age. In fact, some research suggests that women with higher ovarian reserve, which can be more common in younger patients or those with conditions like PCOS, may have a somewhat elevated risk, since their ovaries tend to produce more follicles in response to stimulation. Women over 35 with lower ovarian reserve may have a different risk profile, though individual response to medication protocols varies widely regardless of age.
Recognizing Mild vs. Concerning Symptoms
Mild OHSS symptoms often include bloating, mild abdominal discomfort, and slight weight gain, and these typically resolve within a week or two without specific treatment. More concerning symptoms include rapid weight gain, severe or worsening abdominal pain, persistent nausea or vomiting, decreased urination, shortness of breath, or significant abdominal swelling. Any of these warrant a call to your fertility clinic rather than waiting to see if they improve on their own.
Timing Matters
Symptoms typically emerge within a few days after the egg retrieval procedure, though in some cases they can develop later, particularly if a pregnancy occurs in that cycle, since the hormone hCG associated with early pregnancy can prolong or intensify symptoms.
How Clinics Monitor and Manage Risk
Fertility clinics typically monitor for OHSS risk throughout the stimulation phase using bloodwork and ultrasound to track follicle development and estrogen levels. If a high response is detected, providers may adjust medication protocols, consider a “freeze-all” approach where embryos are frozen rather than transferred fresh, or modify the trigger shot used to finalize egg maturation. These strategies are associated with meaningfully lower rates of moderate to severe OHSS, according to research published on PubMed.
Staying hydrated, monitoring weight and abdominal girth as instructed by your clinic, and avoiding strenuous exercise during the stimulation and early post-retrieval period are commonly recommended supportive measures, though they don’t replace direct communication with your care team if symptoms escalate.
What to Discuss With Your Fertility Team Beforehand
Before starting stimulation, it can help to ask your clinic directly about your individual OHSS risk based on your hormone levels, antral follicle count, and medical history. Understanding your specific treatment plan and monitoring schedule in advance can make it easier to distinguish expected side effects from symptoms that need prompt attention.
Clinics generally provide written guidance on what to watch for and who to call after hours if symptoms arise, and reviewing this information before your retrieval, rather than during a stressful moment afterward, can help you feel more prepared.
Long-Term Outlook After OHSS
For most patients, even moderate OHSS resolves without lasting effects on fertility or overall health once the acute episode has passed. Research indicates that a history of OHSS in one cycle doesn’t necessarily predict future cycles will follow the same pattern, since clinics typically adjust the stimulation protocol for subsequent attempts based on what was learned. This might mean using a lower medication dose, a different trigger shot formulation, or an antagonist protocol designed specifically to reduce OHSS risk in future cycles.
Severe OHSS, while uncommon, can occasionally require hospitalization for fluid management and monitoring, particularly if fluid accumulates significantly in the abdominal or, rarely, chest cavity. Even in these more serious cases, research suggests that outcomes are generally favorable with appropriate medical management, though the experience itself can be frightening and physically uncomfortable while it’s happening.
If you’ve experienced OHSS previously, it’s worth discussing this history explicitly at the start of any future stimulation cycle, since your care team can factor it into planning from the outset rather than reacting after the fact. Many patients who experience OHSS in one cycle go on to have successful, better-tolerated cycles afterward once the protocol has been adjusted to their individual response pattern.
It’s also worth understanding that a positive pregnancy test following a cycle complicated by OHSS doesn’t necessarily mean symptoms will worsen dramatically, though rising hCG levels can prolong the timeline for improvement in some cases. Clinics typically schedule closer follow-up during early pregnancy for patients recovering from moderate OHSS specifically to monitor this overlap. If new or worsening symptoms appear after a positive test, the same guidance applies: contact your clinic rather than assuming it’s an expected part of early pregnancy discomfort.
Frequently Asked Questions
Is OHSS more common in women over 35?
Not necessarily. OHSS risk is more closely tied to ovarian reserve and how strongly the ovaries respond to stimulation medication than to age alone, though every case is individual.
How long does OHSS typically last?
Mild cases often resolve within one to two weeks. If a pregnancy occurs in that cycle, symptoms may persist somewhat longer due to rising pregnancy hormones.
Can OHSS be prevented entirely?
It cannot be fully eliminated, but clinics use monitoring and protocol adjustments to reduce risk, particularly for patients identified as high responders during stimulation.
When should I call my clinic about symptoms?
Contact your clinic promptly if you experience rapid weight gain, severe abdominal pain, persistent vomiting, reduced urination, or difficulty breathing. These symptoms should not wait until a scheduled follow-up.
Can OHSS affect the outcome of the IVF cycle itself?
Moderate to severe OHSS may prompt a clinic to delay embryo transfer and freeze all embryos for a future cycle instead, specifically to allow the body to recover before pregnancy hormones potentially prolong symptoms. This decision is made on a case-by-case basis with your care team.
Key Takeaways
- OHSS is a known potential response to IVF stimulation medications, with most cases classified as mild.
- Risk relates more to ovarian response than age alone, though every stimulation cycle is monitored individually.
- Clinics use bloodwork, ultrasound, and protocol adjustments to reduce the likelihood of moderate to severe cases.
- Knowing which symptoms warrant an urgent call to your clinic can help you respond appropriately if they arise.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.
1 comentário em “Ovarian Hyperstimulation Syndrome After 35: Recognizing the Signs During IVF”